| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.625 | 0.005 | 0.625 | GABA C receptor rho-3 antagonist | 0.395 0.064 CID_115225 0.452 0.041 CID_3025891 | ||
| 0.628 | 0.013 | 0.628 | Aryl hydrocarbon receptor agonist | 0.151 0.135 CID_115225 0.228 0.089 CID_3025891 | ||
| 0.596 | 0.005 | 0.596 | Peroxidase inhibitor | 0.527 0.008 CID_115225 0.448 0.014 CID_3025891 | ||
| 0.521 | 0.025 | 0.521 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.426 0.079 CID_115225 0.373 0.126 CID_3025891 | ||
| 0.518 | 0.022 | 0.518 | Calcium channel L-type activator | 0.395 0.085 CID_3025891 | ||
| 0.501 | 0.008 | 0.501 | Interleukin 2 agonist | 0.462 0.013 CID_3025891 | ||
| 0.504 | 0.012 | 0.504 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.502 | 0.014 | 0.502 | Dyrk kinase inhibitor | |||
| 0.463 | 0.017 | 0.463 | Superoxide dismutase inhibitor | 0.223 0.095 CID_115225 0.295 0.052 CID_3025891 | ||
| 0.46 | 0.034 | 0.46 | 5 Hydroxytryptamine release stimulant | 0.178 0.142 CID_115225 0.249 0.089 CID_3025891 | ||
| 0.458 | 0.039 | 0.458 | Aldehyde oxidase inhibitor | 0.16 0.13 CID_115225 0.286 0.07 CID_3025891 | ||
| 0.446 | 0.036 | 0.446 | MAP kinase kinase 6 inhibitor | 0.237 0.208 CID_3025891 | ||
| 0.442 | 0.055 | 0.442 | 5 Hydroxytryptamine release inhibitor | 0.31 0.154 CID_115225 0.294 0.172 CID_3025891 | ||
| 0.439 | 0.056 | 0.439 | Histamine release inhibitor | 0.276 0.137 CID_3025891 | ||
| 0.415 | 0.035 | 0.415 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.362 | 0.014 | 0.362 | Tyrosine 3 hydroxylase inhibitor | 0.347 0.017 CID_115225 0.264 0.056 CID_3025891 | ||
| 0.37 | 0.024 | 0.37 | Clk dual-specificity kinase inhibitor | |||
| 0.379 | 0.033 | 0.379 | Calcium channel activator | 0.27 0.124 CID_115225 0.305 0.087 CID_3025891 | ||
| 0.35 | 0.01 | 0.35 | Interleukin 6 antagonist | 0.284 0.017 CID_3025891 | ||
| 0.341 | 0.005 | 0.341 | Telomerase inhibitor | 0.132 0.024 CID_3025891 | ||
| 0.342 | 0.007 | 0.342 | GABA C receptor agonist | 0.16 0.03 CID_115225 0.198 0.021 CID_3025891 | ||
| 0.352 | 0.021 | 0.352 | CDC-like kinase 4 inhibitor | |||
| 0.342 | 0.013 | 0.342 | LIM domain kinase 1 inhibitor | 0.135 0.114 CID_3025891 | ||
| 0.424 | 0.097 | 0.424 | Caspase 9 stimulant | 0.389 0.117 CID_115225 0.328 0.165 CID_3025891 | ||
| 0.354 | 0.029 | 0.354 | Sigma receptor agonist | |||
| 0.334 | 0.011 | 0.334 | Neurotrophic factor enhancer | 0.163 0.119 CID_115225 0.269 0.029 CID_3025891 | ||
| 0.336 | 0.015 | 0.336 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.247 0.044 CID_115225 0.311 0.02 CID_3025891 | ||
| 0.356 | 0.039 | 0.371 | DNA damaging | 0.179 0.135 CID_115225 0.371 0.035 CID_3025891 | CID_3025891 | |
| 0.316 | 0.005 | 0.316 | MAP kinase kinase 3 inhibitor | 0.242 0.04 CID_3025891 | ||
| 0.321 | 0.011 | 0.321 | Heat shock protein 90 alpha antagonist | 0.258 0.024 CID_115225 0.242 0.029 CID_3025891 | ||
| 0.33 | 0.026 | 0.33 | MAP kinase kinase 2 inhibitor | 0.172 0.102 CID_115225 0.15 0.121 CID_3025891 | ||
| 0.333 | 0.031 | 0.333 | 5 Hydroxytryptamine uptake stimulant | 0.222 0.114 CID_115225 0.248 0.083 CID_3025891 | ||
| 0.307 | 0.013 | 0.307 | Histone acetyltransferase inhibitor | 0.148 0.143 CID_115225 0.171 0.112 CID_3025891 | ||
| 0.376 | 0.085 | 0.376 | 15-Lipoxygenase inhibitor | 0.291 0.137 CID_3025891 | ||
| 0.32 | 0.031 | 0.32 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.292 | 0.005 | 0.292 | T cell inhibitor | 0.132 0.012 CID_3025891 | ||
| 0.322 | 0.038 | 0.322 | Interleukin agonist | 0.274 0.063 CID_3025891 | ||
| 0.326 | 0.045 | 0.37 | Tumour necrosis factor alpha release inhibitor | 0.37 0.033 CID_115225 0.253 0.073 CID_3025891 | CID_115225 | |
| 0.308 | 0.029 | 0.308 | CDC-like kinase 2 inhibitor | |||
| 0.307 | 0.03 | 0.307 | RNA-directed DNA polymerase inhibitor | 0.265 0.042 CID_3025891 | ||
| 0.31 | 0.036 | 0.31 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.307 | 0.033 | 0.307 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.28 | 0.007 | 0.28 | GABA C receptor rho-2 antagonist | 0.154 0.068 CID_115225 0.163 0.058 CID_3025891 | ||
| 0.272 | 0.006 | 0.272 | Protein kinase C zeta inhibitor | 0.136 0.024 CID_3025891 | ||
| 0.279 | 0.014 | 0.279 | Heat shock protein 90 antagonist | 0.2 0.038 CID_115225 0.276 0.014 CID_3025891 | ||
| 0.267 | 0.005 | 0.267 | GABA C receptor antagonist | 0.187 0.016 CID_115225 0.159 0.025 CID_3025891 | ||
| 0.271 | 0.01 | 0.271 | Interleukin 1b antagonist | 0.103 0.078 CID_115225 0.151 0.04 CID_3025891 | ||
| 0.273 | 0.014 | 0.273 | Hexokinase inhibitor | 0.122 0.115 CID_115225 0.209 0.03 CID_3025891 | ||
| 0.292 | 0.035 | 0.292 | Anesthetic general | 0.292 0.035 CID_3025891 | ||
| 0.296 | 0.045 | 0.373 | DNA synthesis inhibitor | 0.373 0.026 CID_3025891 | CID_3025891 | |
| 0.333 | 0.082 | 0.428 | Transcription factor NF kappa B inhibitor | 0.428 0.057 CID_3025891 | CID_3025891 | |
| 0.255 | 0.005 | 0.255 | HIV-1 integrase (Overall Integration) inhibitor | 0.105 0.05 CID_115225 0.162 0.021 CID_3025891 | ||
| 0.264 | 0.016 | 0.264 | Interleukin 1 antagonist | 0.168 0.047 CID_3025891 | ||
| 0.286 | 0.04 | 0.286 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.306 | 0.06 | 0.306 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.256 | 0.011 | 0.256 | Carbonic anhydrase XV inhibitor | 0.131 0.039 CID_3025891 | ||
| 0.271 | 0.03 | 0.271 | Protein kinase C nu inhibitor | |||
| 0.275 | 0.035 | 0.275 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.268 | 0.028 | 0.268 | I kappa B kinase epsilon inhibitor | |||
| 0.315 | 0.076 | 0.315 | Vasodilator, coronary | 0.297 0.09 CID_3025891 | ||
| 0.252 | 0.015 | 0.252 | 5 Hydroxytryptamine 3E antagonist | 0.196 0.069 CID_115225 | ||
| 0.25 | 0.013 | 0.25 | Ferrochelatase inhibitor | 0.136 0.044 CID_115225 0.11 0.061 CID_3025891 | ||
| 0.241 | 0.004 | 0.241 | Potassium channel (Ca-activated) blocker | |||
| 0.253 | 0.02 | 0.253 | Toll-Like receptor 9 antagonist | |||
| 0.255 | 0.022 | 0.3 | Alpha-N-acetylglucosaminidase inhibitor | 0.191 0.037 CID_115225 0.3 0.016 CID_3025891 | CID_3025891 | |
| 0.233 | 0.005 | 0.233 | GABA C receptor rho-1 antagonist | 0.104 0.056 CID_115225 0.131 0.032 CID_3025891 | ||
| 0.256 | 0.032 | 0.269 | Lipocortins synthesis antagonist | 0.139 0.123 CID_115225 0.269 0.028 CID_3025891 | CID_3025891 | |
| 0.272 | 0.051 | 0.272 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.243 | 0.023 | 0.243 | Hemostatic | 0.176 0.045 CID_3025891 | ||
| 0.272 | 0.054 | 0.272 | Cyclic AMP phosphodiesterase inhibitor | 0.19 0.102 CID_3025891 | ||
| 0.232 | 0.018 | 0.232 | Cystathionine beta-synthase inhibitor | 0.117 0.06 CID_115225 0.175 0.031 CID_3025891 | ||
| 0.237 | 0.024 | 0.237 | Ribosomal protein S6 kinase inhibitor | |||
| 0.282 | 0.07 | 0.282 | Insulysin inhibitor | 0.277 0.074 CID_115225 | ||
| 0.215 | 0.006 | 0.215 | Phenylalanine 4-hydroxylase inhibitor | 0.191 0.007 CID_115225 0.133 0.015 CID_3025891 | ||
| 0.292 | 0.084 | 0.292 | 12-Lipoxygenase inhibitor | 0.187 0.166 CID_115225 | ||
| 0.218 | 0.013 | 0.218 | CF transmembrane conductance regulator agonist | 0.13 0.119 CID_115225 0.174 0.042 CID_3025891 | ||
| 0.255 | 0.051 | 0.255 | Death-associated protein kinase 3 inhibitor | |||
| 0.235 | 0.032 | 0.235 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.208 | 0.004 | 0.208 | Glutamate release inhibitor | 0.089 0.065 CID_115225 0.118 0.023 CID_3025891 | ||
| 0.227 | 0.024 | 0.227 | CDC-like kinase 1 inhibitor | |||
| 0.236 | 0.035 | 0.236 | Tumour necrosis factor antagonist | 0.172 0.075 CID_115225 | ||
| 0.262 | 0.065 | 0.263 | Gastrin inhibitor | 0.21 0.133 CID_115225 0.263 0.064 CID_3025891 | CID_3025891 | |
| 0.211 | 0.014 | 0.211 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.149 0.075 CID_115225 | ||
| 0.27 | 0.074 | 0.27 | Transcription factor STAT inhibitor | 0.214 0.119 CID_115225 | ||
| 0.208 | 0.013 | 0.208 | 5 Hydroxytryptamine 3A agonist | |||
| 0.237 | 0.042 | 0.237 | Nitric-oxide synthase stimulant | 0.218 0.063 CID_3025891 | ||
| 0.216 | 0.023 | 0.216 | Mannose-6-phosphate isomerase inhibitor | 0.148 0.066 CID_115225 0.165 0.052 CID_3025891 | ||
| 0.197 | 0.005 | 0.197 | CD45 antagonist | 0.047 0.043 CID_115225 0.058 0.023 CID_3025891 | ||
| 0.237 | 0.044 | 0.237 | Focal adhesion kinase 2 inhibitor | 0.15 0.13 CID_115225 | ||
| 0.217 | 0.026 | 0.217 | Cyclin-dependent kinase 8 inhibitor | 0.158 0.071 CID_3025891 | ||
| 0.223 | 0.034 | 0.223 | Succinate dehydrogenase inhibitor | 0.178 0.07 CID_115225 0.161 0.094 CID_3025891 | ||
| 0.263 | 0.074 | 0.263 | Transcription factor STAT3 inhibitor | |||
| 0.238 | 0.052 | 0.238 | TRKC antagonist | |||
| 0.292 | 0.106 | 0.292 | Prostaglandin dehydrogenase inhibitor | |||
| 0.218 | 0.034 | 0.218 | Phospholipase C inhibitor | 0.147 0.112 CID_115225 0.212 0.037 CID_3025891 | ||
| 0.195 | 0.016 | 0.206 | Adenylate kinase inhibitor | 0.127 0.038 CID_115225 0.206 0.014 CID_3025891 | CID_3025891 | |
| 0.201 | 0.022 | 0.201 | MAP kinase 12 inhibitor | |||
| 0.234 | 0.06 | 0.234 | ErbB-1 antagonist | |||
| 0.185 | 0.012 | 0.185 | DNA repair enzyme inhibitor | 0.166 0.02 CID_3025891 | ||
| 0.218 | 0.045 | 0.218 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.236 | 0.064 | 0.236 | Psychostimulant | 0.219 0.07 CID_3025891 | ||
| 0.239 | 0.067 | 0.239 | Neuropeptide Y2 antagonist | |||
| 0.205 | 0.038 | 0.205 | Protein kinase (CK1) inhibitor | |||
| 0.194 | 0.028 | 0.375 | Alkylator | 0.176 0.034 CID_115225 0.375 0.009 CID_3025891 | CID_3025891 | |
| 0.179 | 0.014 | 0.179 | Nitric-oxide synthase inhibitor | |||
| 0.206 | 0.042 | 0.206 | Protein kinase (CK1) gamma inhibitor | |||
| 0.2 | 0.037 | 0.2 | Activin receptor-like kinase 2 inhibitor | |||
| 0.17 | 0.008 | 0.17 | Acetylcholine release stimulant | 0.101 0.084 CID_3025891 | ||
| 0.195 | 0.033 | 0.195 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.196 | 0.035 | 0.196 | Catenin beta inhibitor | |||
| 0.203 | 0.045 | 0.203 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.161 | 0.006 | 0.161 | NMDA 2C receptor antagonist | 0.067 0.036 CID_3025891 | ||
| 0.174 | 0.021 | 0.174 | Carbonic anhydrase III inhibitor | 0.121 0.044 CID_115225 0.117 0.047 CID_3025891 | ||
| 0.174 | 0.022 | 0.174 | Ca(v)2.2 blocker | |||
| 0.166 | 0.015 | 0.166 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.123 0.028 CID_3025891 | ||
| 0.155 | 0.007 | 0.155 | GABA aminotransferase inhibitor | 0.076 0.052 CID_115225 0.111 0.02 CID_3025891 | ||
| 0.188 | 0.041 | 0.188 | Tubulin antagonist | 0.183 0.043 CID_3025891 | ||
| 0.169 | 0.023 | 0.169 | Protein kinase C gamma inhibitor | 0.104 0.07 CID_3025891 | ||
| 0.151 | 0.005 | 0.151 | D-Ala-D-Ala ligase inhibitor | 0.097 0.033 CID_115225 0.108 0.021 CID_3025891 | ||
| 0.176 | 0.03 | 0.176 | Adenylate cyclase stimulant | 0.144 0.073 CID_115225 0.175 0.03 CID_3025891 | ||
| 0.167 | 0.022 | 0.167 | Photosensitizer | 0.117 0.061 CID_115225 0.117 0.061 CID_3025891 | ||
| 0.149 | 0.005 | 0.149 | Granulocyte macrophage colony stimulating factor agonist | 0.093 0.046 CID_115225 0.09 0.052 CID_3025891 | ||
| 0.148 | 0.004 | 0.148 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.114 0.007 CID_115225 0.115 0.007 CID_3025891 | ||
| 0.174 | 0.032 | 0.174 | Cathepsin H inhibitor | 0.13 0.063 CID_3025891 | ||
| 0.207 | 0.066 | 0.207 | Non-steroidal antiinflammatory agent | 0.185 0.084 CID_115225 | ||
| 0.158 | 0.017 | 0.158 | Rho-associated kinase inhibitor | |||
| 0.156 | 0.016 | 0.166 | NADH dehydrogenase inhibitor | 0.093 0.052 CID_115225 0.166 0.014 CID_3025891 | CID_3025891 | |
| 0.161 | 0.022 | 0.162 | Ca2+-transporting ATPase inhibitor | 0.143 0.061 CID_115225 0.162 0.022 CID_3025891 | CID_3025891 | |
| 0.172 | 0.033 | 0.172 | Nav1.6 sodium channel blocker | |||
| 0.15 | 0.014 | 0.15 | Histamine N-methyltransferase inhibitor | 0.095 0.05 CID_3025891 | ||
| 0.15 | 0.014 | 0.15 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.151 | 0.016 | 0.151 | I kappa B kinase inhibitor | |||
| 0.151 | 0.016 | 0.151 | CYP2A6 inhibitor | 0.084 0.045 CID_115225 | ||
| 0.139 | 0.005 | 0.139 | Poly(ADP-ribose) polymerase 2 inhibitor | |||
| 0.169 | 0.034 | 0.172 | Adenylate cyclase inhibitor | 0.127 0.062 CID_115225 0.172 0.033 CID_3025891 | CID_3025891 | |
| 0.151 | 0.017 | 0.151 | Rho-associated kinase II inhibitor | |||
| 0.184 | 0.05 | 0.187 | Arachidonic acid antagonist | 0.187 0.046 CID_3025891 | CID_3025891 | |
| 0.224 | 0.09 | 0.224 | Calpain inhibitor | |||
| 0.185 | 0.052 | 0.23 | ATPase inhibitor | 0.23 0.02 CID_115225 0.217 0.026 CID_3025891 | CID_115225 | |
| 0.143 | 0.01 | 0.143 | I kappa B kinase 1 inhibitor | |||
| 0.146 | 0.013 | 0.146 | Lanosterol 14 alpha demethylase inhibitor | 0.096 0.061 CID_115225 0.114 0.037 CID_3025891 | ||
| 0.16 | 0.028 | 0.16 | Interleukin 8 antagonist | |||
| 0.152 | 0.02 | 0.152 | Porphobilinogen synthase inhibitor | 0.074 0.052 CID_115225 0.064 0.062 CID_3025891 | ||
| 0.219 | 0.087 | 0.219 | Antiamyloidogenic | |||
| 0.152 | 0.02 | 0.152 | DOPA decarboxylase inhibitor | 0.101 0.073 CID_115225 0.105 0.066 CID_3025891 | ||
| 0.147 | 0.016 | 0.147 | Toll-Like receptor 3 antagonist | |||
| 0.153 | 0.023 | 0.153 | Creatine kinase inhibitor | 0.101 0.058 CID_115225 0.141 0.028 CID_3025891 | ||
| 0.148 | 0.018 | 0.148 | Pim-3 kinase inhibitor | 0.084 0.069 CID_3025891 | ||
| 0.171 | 0.042 | 0.171 | Toll-Like receptor antagonist | |||
| 0.179 | 0.05 | 0.179 | Lck kinase inhibitor | |||
| 0.178 | 0.05 | 0.178 | Thiol protease inhibitor | |||
| 0.169 | 0.041 | 0.169 | Anesthetic local | 0.113 0.073 CID_3025891 | ||
| 0.137 | 0.009 | 0.137 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.2 | 0.073 | 0.2 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.158 | 0.034 | 0.158 | MAP kinase 9 inhibitor | |||
| 0.133 | 0.009 | 0.133 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.145 | 0.022 | 0.145 | Alcohol dehydrogenase inhibitor | |||
| 0.139 | 0.016 | 0.139 | Interleukin 12 antagonist | 0.118 0.031 CID_3025891 | ||
| 0.158 | 0.036 | 0.158 | Alpha 2b adrenoreceptor antagonist | |||
| 0.176 | 0.054 | 0.176 | Neurotensin receptor agonist | |||
| 0.167 | 0.046 | 0.213 | MAP kinase 3 inhibitor | 0.213 0.018 CID_115225 | CID_115225 | |
| 0.13 | 0.009 | 0.13 | CDC25B inhibitor | 0.058 0.053 CID_3025891 | ||
| 0.247 | 0.128 | 0.247 | Cholesterol antagonist | 0.2 0.165 CID_3025891 | ||
| 0.143 | 0.025 | 0.143 | Protein kinase C delta inhibitor | |||
| 0.147 | 0.03 | 0.163 | UDP-glucose 4-epimerase inhibitor | 0.135 0.035 CID_115225 0.163 0.025 CID_3025891 | CID_3025891 | |
| 0.136 | 0.02 | 0.136 | NMDA 2 receptor antagonist | 0.083 0.041 CID_3025891 | ||
| 0.273 | 0.157 | 0.476 | Antibacterial | 0.476 0.048 CID_3025891 | CID_3025891 | |
| 0.16 | 0.046 | 0.16 | MAP3K9 inhibitor | |||
| 0.122 | 0.008 | 0.122 | I kappa B kinase 2 inhibitor | |||
| 0.232 | 0.117 | 0.256 | Hypoxia-inducible factor 1 alpha inhibitor | 0.256 0.095 CID_3025891 | CID_3025891 | |
| 0.143 | 0.029 | 0.143 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.087 0.07 CID_115225 0.111 0.045 CID_3025891 | ||
| 0.241 | 0.13 | 0.241 | Angiogenesis inhibitor | |||
| 0.143 | 0.033 | 0.143 | CC chemokine 6 receptor antagonist | 0.121 0.112 CID_115225 0.137 0.047 CID_3025891 | ||
| 0.141 | 0.031 | 0.141 | Potassium channel (Ca-activated) activator | |||
| 0.142 | 0.033 | 0.142 | MAP kinase 8 inhibitor | |||
| 0.157 | 0.048 | 0.157 | MAP kinase kinase inhibitor | 0.145 0.054 CID_115225 | ||
| 0.154 | 0.045 | 0.154 | Aldehyde dehydrogenase inhibitor | |||
| 0.116 | 0.009 | 0.116 | AMPA receptor antagonist | 0.097 0.013 CID_115225 | ||
| 0.132 | 0.025 | 0.132 | Carbonic anhydrase VI inhibitor | 0.083 0.054 CID_3025891 | ||
| 0.175 | 0.069 | 0.175 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.135 | 0.03 | 0.135 | Catalase inhibitor | |||
| 0.158 | 0.053 | 0.158 | Neuropeptide Y1 antagonist | |||
| 0.155 | 0.05 | 0.155 | Protein kinase (CK1) delta inhibitor | |||
| 0.125 | 0.02 | 0.125 | Rho-associated kinase I inhibitor | |||
| 0.144 | 0.039 | 0.144 | Sphingosine 1-phosphate receptor 4 antagonist | 0.11 0.094 CID_3025891 | ||
| 0.286 | 0.183 | 0.572 | Apoptosis agonist | 0.572 0.055 CID_3025891 | CID_3025891 | |
| 0.118 | 0.014 | 0.118 | Biliverdin reductase inhibitor | 0.054 0.047 CID_115225 0.106 0.017 CID_3025891 | ||
| 0.15 | 0.046 | 0.15 | Heat shock protein 70 antagonist | 0.131 0.117 CID_3025891 | ||
| 0.127 | 0.024 | 0.127 | Histidine decarboxylase inhibitor | 0.091 0.036 CID_3025891 | ||
| 0.143 | 0.041 | 0.143 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.117 | 0.015 | 0.123 | Alcohol oxidase inhibitor | 0.053 0.042 CID_115225 0.123 0.014 CID_3025891 | CID_3025891 | |
| 0.116 | 0.014 | 0.116 | Glycine receptor agonist | 0.078 0.042 CID_115225 0.114 0.014 CID_3025891 | ||
| 0.129 | 0.027 | 0.154 | Triose-phosphate isomerase inhibitor | 0.154 0.019 CID_115225 0.126 0.029 CID_3025891 | CID_115225 | |
| 0.127 | 0.025 | 0.127 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.132 | 0.031 | 0.132 | Prolactin inhibitor | 0.081 0.08 CID_115225 | ||
| 0.105 | 0.005 | 0.105 | Transcription factor RelA inhibitor | 0.077 0.02 CID_3025891 | ||
| 0.12 | 0.021 | 0.12 | Purinergic P2X2 antagonist | |||
| 0.152 | 0.053 | 0.152 | NADPH oxidase inhibitor | |||
| 0.107 | 0.008 | 0.107 | Glutamate (mGluR6) antagonist | 0.069 0.042 CID_115225 0.09 0.015 CID_3025891 | ||
| 0.132 | 0.035 | 0.132 | Pim-1 kinase inhibitor | |||
| 0.128 | 0.032 | 0.128 | Phosphodiesterase 7B inhibitor | |||
| 0.119 | 0.025 | 0.119 | Inducible nitric-oxide synthase inhibitor | |||
| 0.107 | 0.013 | 0.121 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.058 0.037 CID_115225 0.121 0.011 CID_3025891 | CID_3025891 | |
| 0.103 | 0.01 | 0.103 | Heat shock protein 90 beta antagonist | 0.095 0.012 CID_3025891 | ||
| 0.102 | 0.009 | 0.102 | Glutamate (mGluR7) antagonist | 0.063 0.058 CID_115225 0.067 0.049 CID_3025891 | ||
| 0.184 | 0.091 | 0.184 | Pyruvate kinase inhibitor | 0.139 0.126 CID_115225 | ||
| 0.114 | 0.021 | 0.114 | CDC25A inhibitor | 0.07 0.057 CID_3025891 | ||
| 0.175 | 0.083 | 0.175 | DNA methyltransferase I inhibitor | |||
| 0.109 | 0.018 | 0.119 | Carbamoyl phosphate synthetase inhibitor | 0.056 0.048 CID_115225 0.119 0.016 CID_3025891 | CID_3025891 | |
| 0.124 | 0.033 | 0.124 | Electrolyte absorption antagonist | |||
| 0.155 | 0.063 | 0.155 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.135 | 0.044 | 0.135 | Falcipain 3 inhibitor | |||
| 0.1 | 0.009 | 0.1 | Exportin-1 inhibitor | 0.063 0.062 CID_3025891 | ||
| 0.123 | 0.034 | 0.123 | NMDA receptor antagonist | |||
| 0.104 | 0.015 | 0.104 | Purinergic P2X1 antagonist | 0.099 0.017 CID_3025891 | ||
| 0.111 | 0.023 | 0.111 | mTOR complex 2 inhibitor | |||
| 0.164 | 0.077 | 0.215 | Death-associated protein kinase 2 inhibitor | 0.215 0.025 CID_115225 | CID_115225 | |
| 0.162 | 0.076 | 0.162 | Src kinase inhibitor | |||
| 0.09 | 0.004 | 0.09 | Alpha 1d adrenoreceptor agonist | 0.052 0.015 CID_115225 | ||
| 0.134 | 0.048 | 0.169 | Topoisomerase I inhibitor | 0.169 0.035 CID_3025891 | CID_3025891 | |
| 0.109 | 0.024 | 0.109 | Alpha adrenoreceptor agonist | |||
| 0.107 | 0.022 | 0.107 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.12 | 0.035 | 0.12 | MAP kinase kinase 1 inhibitor | |||
| 0.09 | 0.006 | 0.09 | Prolactin release inhibitor | 0.073 0.018 CID_3025891 | ||
| 0.108 | 0.025 | 0.108 | Check point kinase 1 inhibitor | |||
| 0.089 | 0.006 | 0.089 | Alpha 1b adrenoreceptor agonist | 0.047 0.042 CID_3025891 | ||
| 0.088 | 0.005 | 0.088 | Thymidylate synthase inhibitor | 0.068 0.013 CID_115225 0.062 0.016 CID_3025891 | ||
| 0.103 | 0.021 | 0.103 | Protein kinase C alpha inhibitor | |||
| 0.11 | 0.028 | 0.127 | Phosphofructokinase-1 inhibitor | 0.065 0.052 CID_115225 0.127 0.023 CID_3025891 | CID_3025891 | |
| 0.099 | 0.017 | 0.099 | GABA B receptor agonist | 0.08 0.042 CID_115225 0.072 0.063 CID_3025891 | ||
| 0.096 | 0.014 | 0.096 | NMDA 2A receptor antagonist | |||
| 0.148 | 0.066 | 0.148 | MAP kinase kinase 4 inhibitor | |||
| 0.134 | 0.052 | 0.134 | Protein kinase (CK2) alpha inhibitor | |||
| 0.129 | 0.048 | 0.135 | Aminopeptidase B inhibitor | 0.135 0.044 CID_115225 | CID_115225 | |
| 0.097 | 0.016 | 0.097 | MAP kinase kinase 7 inhibitor | 0.089 0.026 CID_3025891 | ||
| 0.086 | 0.006 | 0.086 | AICAR transformylase inhibitor | 0.067 0.011 CID_3025891 | ||
| 0.121 | 0.042 | 0.121 | CDC-like kinase 3 inhibitor | |||
| 0.226 | 0.148 | 0.226 | Vasodilator, peripheral | |||
| 0.096 | 0.017 | 0.096 | Phospholipase D inhibitor | |||
| 0.159 | 0.081 | 0.159 | Mcl-1 antagonist | |||
| 0.104 | 0.026 | 0.104 | Interferon agonist | 0.085 0.044 CID_3025891 | ||
| 0.129 | 0.052 | 0.212 | Microtubule formation inhibitor | 0.212 0.017 CID_3025891 | CID_3025891 | |
| 0.13 | 0.052 | 0.13 | DNA intercalator | 0.102 0.072 CID_3025891 | ||
| 0.139 | 0.062 | 0.139 | Acetylcholinesterase inhibitor | 0.125 0.074 CID_3025891 | ||
| 0.116 | 0.039 | 0.116 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.132 | 0.055 | 0.132 | Beta amyloid protein antagonist | |||
| 0.105 | 0.028 | 0.105 | Glutamate dehydrogenase inhibitor | 0.104 0.029 CID_3025891 | ||
| 0.123 | 0.047 | 0.123 | Check point kinase 2 inhibitor | |||
| 0.085 | 0.009 | 0.085 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.093 | 0.018 | 0.093 | Acyl-CoA dehydrogenase inhibitor | 0.089 0.019 CID_3025891 | ||
| 0.113 | 0.037 | 0.113 | Protein kinase A inhibitor | |||
| 0.087 | 0.011 | 0.087 | Aconitate hydratase inhibitor | 0.059 0.027 CID_115225 0.055 0.032 CID_3025891 | ||
| 0.145 | 0.07 | 0.145 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.089 | 0.015 | 0.089 | Kallikrein 1 inhibitor | |||
| 0.175 | 0.101 | 0.175 | Insulin sensitizer | |||
| 0.104 | 0.03 | 0.104 | Myeloperoxidase inhibitor | |||
| 0.108 | 0.034 | 0.108 | Carbonic anhydrase XIII inhibitor | |||
| 0.078 | 0.005 | 0.078 | Dihydrofolate reductase inhibitor | |||
| 0.091 | 0.018 | 0.091 | Alpha 2 adrenoreceptor agonist | |||
| 0.206 | 0.134 | 0.206 | Lipoxygenase inhibitor | 0.2 0.14 CID_115225 | ||
| 0.076 | 0.005 | 0.076 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.031 0.017 CID_115225 0.063 0.007 CID_3025891 | ||
| 0.079 | 0.008 | 0.079 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.078 | 0.007 | 0.078 | Immunoglobulin Fc receptor antagonist | 0.076 0.007 CID_115225 | ||
| 0.111 | 0.041 | 0.111 | Potassium channel (Voltage-sensitive) activator | |||
| 0.17 | 0.1 | 0.17 | DNA methylase inhibitor | |||
| 0.115 | 0.045 | 0.138 | Sphingomyelinase inhibitor | 0.138 0.03 CID_115225 | CID_115225 | |
| 0.09 | 0.02 | 0.09 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.09 | 0.02 | 0.09 | 5 Hydroxytryptamine 3 agonist | |||
| 0.103 | 0.034 | 0.103 | MAP kinase 11 inhibitor | |||
| 0.088 | 0.019 | 0.088 | Carbonic anhydrase VB inhibitor | |||
| 0.119 | 0.05 | 0.119 | Alpha 2c adrenoreceptor antagonist | |||
| 0.082 | 0.013 | 0.082 | Calcium channel P-type blocker | |||
| 0.129 | 0.061 | 0.285 | Topoisomerase II inhibitor | 0.285 0.02 CID_3025891 | CID_3025891 | |
| 0.135 | 0.068 | 0.135 | Nav1.2 sodium channel blocker | |||
| 0.141 | 0.074 | 0.141 | Cell wall synthesis inhibitor | 0.138 0.077 CID_3025891 | ||
| 0.175 | 0.108 | 0.206 | Angiogenesis stimulant | 0.206 0.091 CID_3025891 | CID_3025891 | |
| 0.099 | 0.032 | 0.099 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.088 | 0.022 | 0.088 | Argininosuccinate synthase inhibitor | 0.088 0.022 CID_3025891 | ||
| 0.097 | 0.031 | 0.106 | Glutamate decarboxylase inhibitor | 0.106 0.027 CID_115225 0.067 0.059 CID_3025891 | CID_115225 | |
| 0.079 | 0.013 | 0.079 | Epithelial sodium channel blocker | |||
| 0.07 | 0.005 | 0.07 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.041 0.029 CID_115225 0.05 0.014 CID_3025891 | ||
| 0.081 | 0.016 | 0.081 | Botulinum neurotoxin type A inhibitor | 0.067 0.029 CID_115225 0.059 0.04 CID_3025891 | ||
| 0.137 | 0.072 | 0.137 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.137 | 0.073 | 0.137 | Cytokine production inhibitor | |||
| 0.095 | 0.031 | 0.095 | Estrogen-related receptor beta agonist | 0.088 0.046 CID_3025891 | ||
| 0.098 | 0.034 | 0.098 | Glycine receptor antagonist | 0.082 0.053 CID_115225 0.091 0.041 CID_3025891 | ||
| 0.08 | 0.017 | 0.081 | Potassium channel intermediate-conductance Ca-activated blocker | 0.081 0.017 CID_115225 | CID_115225 | |
| 0.074 | 0.011 | 0.074 | Kainate receptor antagonist | 0.067 0.013 CID_115225 | ||
| 0.099 | 0.037 | 0.099 | Alpha 2a adrenoreceptor antagonist | |||
| 0.077 | 0.014 | 0.077 | Topoisomerase II beta inhibitor | 0.05 0.033 CID_3025891 | ||
| 0.071 | 0.008 | 0.071 | Dopamine D5 agonist | 0.037 0.033 CID_115225 0.043 0.024 CID_3025891 | ||
| 0.228 | 0.166 | 0.228 | Calpain 2 inhibitor | |||
| 0.088 | 0.027 | 0.088 | Secretase beta inhibitor | |||
| 0.128 | 0.067 | 0.128 | Glutamate receptor antagonist | |||
| 0.11 | 0.05 | 0.129 | Anabolic | 0.129 0.031 CID_3025891 | CID_3025891 | |
| 0.095 | 0.035 | 0.095 | Caspase 7 inhibitor | |||
| 0.084 | 0.026 | 0.084 | NMDA receptor glycine site agonist | 0.064 0.042 CID_115225 | ||
| 0.092 | 0.035 | 0.092 | Histone deacetylase SIRT2 inhibitor | |||
| 0.116 | 0.06 | 0.116 | GABA receptor agonist | |||
| 0.123 | 0.067 | 0.123 | Histone deacetylase class III inhibitor | |||
| 0.084 | 0.028 | 0.095 | Histone deacetylase inhibitor | 0.095 0.02 CID_115225 | CID_115225 | |
| 0.127 | 0.071 | 0.127 | Toll-Like receptor 2 antagonist | |||
| 0.083 | 0.027 | 0.083 | Protein kinase C beta inhibitor | |||
| 0.064 | 0.01 | 0.064 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.064 | 0.01 | 0.064 | GABA B receptor antagonist | 0.042 0.032 CID_3025891 | ||
| 0.062 | 0.008 | 0.062 | Nerve growth factor antagonist | |||
| 0.088 | 0.035 | 0.088 | Aminopeptidase I inhibitor | 0.071 0.052 CID_3025891 | ||
| 0.092 | 0.039 | 0.092 | MAP kinase 14 inhibitor | |||
| 0.07 | 0.017 | 0.07 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.108 | 0.057 | 0.108 | Protein kinase (CK2) inhibitor | |||
| 0.074 | 0.023 | 0.074 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.09 | 0.038 | 0.09 | Transforming growth factor beta 3 antagonist | |||
| 0.066 | 0.015 | 0.066 | NMDA receptor subunit 3A antagonist | |||
| 0.137 | 0.086 | 0.137 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.065 | 0.015 | 0.065 | Poly(ADP-ribose) polymerase inhibitor | |||
| 0.106 | 0.056 | 0.106 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.062 | 0.012 | 0.062 | Geranyltranstransferase inhibitor | 0.04 0.036 CID_3025891 | ||
| 0.117 | 0.067 | 0.117 | Calcium channel N-type blocker | |||
| 0.076 | 0.027 | 0.076 | Interferon inducer | 0.064 0.044 CID_3025891 | ||
| 0.131 | 0.082 | 0.139 | Protein kinase stimulant | 0.136 0.079 CID_115225 0.139 0.076 CID_3025891 | CID_3025891 | |
| 0.118 | 0.069 | 0.118 | TRKA antagonist | |||
| 0.064 | 0.016 | 0.064 | Sodium/calcium exchanger inhibitor | |||
| 0.135 | 0.087 | 0.135 | Pregnane X receptor agonist | |||
| 0.068 | 0.02 | 0.068 | Lysine-specific demethylase 1A inhibitor | |||
| 0.095 | 0.047 | 0.095 | Bromodomain-containing protein 2 inhibitor | |||
| 0.097 | 0.05 | 0.097 | Alpha 2 adrenoreceptor antagonist | |||
| 0.058 | 0.01 | 0.063 | Acid-sensing ion channel blocker | 0.063 0.008 CID_115225 | CID_115225 | |
| 0.069 | 0.022 | 0.069 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.048 0.047 CID_115225 | ||
| 0.071 | 0.024 | 0.071 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.057 | 0.011 | 0.057 | Histamine H1 receptor agonist | |||
| 0.057 | 0.011 | 0.057 | GABA uptake inhibitor | |||
| 0.16 | 0.115 | 0.16 | MAP kinase kinase 5 inhibitor | |||
| 0.054 | 0.009 | 0.054 | Glutamate (mGluR8) agonist | 0.041 0.02 CID_3025891 | ||
| 0.072 | 0.028 | 0.072 | 5 Hydroxytryptamine 6 antagonist | 0.052 0.045 CID_115225 | ||
| 0.089 | 0.045 | 0.089 | Glutamate receptor agonist | |||
| 0.101 | 0.057 | 0.101 | Glutamate (mGluR7) agonist | |||
| 0.08 | 0.037 | 0.08 | Carbonic anhydrase VA inhibitor | |||
| 0.079 | 0.036 | 0.079 | Carbonic anhydrase V inhibitor | |||
| 0.068 | 0.025 | 0.068 | Urokinase inhibitor | |||
| 0.134 | 0.091 | 0.134 | Acetylcholine M1 receptor antagonist | |||
| 0.094 | 0.051 | 0.094 | Ornithine decarboxylase inhibitor | 0.081 0.066 CID_3025891 | ||
| 0.123 | 0.081 | 0.123 | Sodium channel blocker | |||
| 0.06 | 0.019 | 0.06 | NMDA receptor subunit 3B antagonist | |||
| 0.059 | 0.019 | 0.059 | Adenylate cyclase 1 inhibitor | 0.041 0.04 CID_115225 0.046 0.031 CID_3025891 | ||
| 0.121 | 0.081 | 0.121 | Amylase inhibitor | 0.112 0.086 CID_3025891 | ||
| 0.11 | 0.071 | 0.11 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.043 | 0.004 | 0.043 | Alpha 2a adrenoreceptor agonist | 0.017 0.012 CID_115225 | ||
| 0.113 | 0.074 | 0.123 | Transcription factor STAT6 inhibitor | 0.123 0.054 CID_115225 | CID_115225 | |
| 0.065 | 0.027 | 0.093 | Alpha tubulin antagonist | 0.093 0.016 CID_3025891 | CID_3025891 | |
| 0.201 | 0.163 | 0.201 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.072 | 0.034 | 0.072 | NMDA receptor agonist | |||
| 0.054 | 0.017 | 0.054 | Glutamate (mGluR group III) antagonist | 0.044 0.03 CID_115225 | ||
| 0.064 | 0.027 | 0.064 | Pim-2 kinase inhibitor | |||
| 0.059 | 0.022 | 0.063 | Adenosine deaminase inhibitor | 0.063 0.018 CID_115225 0.061 0.02 CID_3025891 | CID_115225 | |
| 0.055 | 0.018 | 0.055 | Histamine H2 receptor agonist | |||
| 0.045 | 0.008 | 0.045 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.055 | 0.018 | 0.055 | Cytokine production stimulant | |||
| 0.056 | 0.02 | 0.056 | Dopamine beta hydroxylase inhibitor | |||
| 0.051 | 0.015 | 0.051 | Glutamate (mGluR group II) agonist | |||
| 0.04 | 0.004 | 0.04 | Complement factor 1s inhibitor | |||
| 0.07 | 0.034 | 0.07 | Beta tubulin antagonist | 0.059 0.04 CID_3025891 | ||
| 0.137 | 0.101 | 0.149 | Melanin inhibitor | 0.13 0.115 CID_115225 0.149 0.083 CID_3025891 | CID_3025891 | |
| 0.12 | 0.085 | 0.12 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.056 | 0.022 | 0.056 | Histamine H4 receptor antagonist | |||
| 0.113 | 0.08 | 0.113 | c-Src kinase inhibitor | |||
| 0.05 | 0.017 | 0.05 | Dihydropteroate synthase inhibitor | |||
| 0.066 | 0.033 | 0.066 | Cyclin D1 inhibitor | |||
| 0.052 | 0.019 | 0.052 | Glutamate (mGluR4) antagonist | 0.046 0.025 CID_115225 | ||
| 0.047 | 0.015 | 0.047 | Glutamate (mGluR2) agonist | |||
| 0.102 | 0.069 | 0.102 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.045 | 0.013 | 0.045 | Purinergic P2Y2 antagonist | |||
| 0.036 | 0.004 | 0.036 | Alpha 2c adrenoreceptor agonist | |||
| 0.049 | 0.018 | 0.049 | Poly(ADP-ribose) polymerase 1 inhibitor | |||
| 0.036 | 0.005 | 0.036 | Imidazoline I1 receptor antagonist | |||
| 0.043 | 0.012 | 0.043 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.085 | 0.054 | 0.085 | Histamine H2 receptor antagonist | |||
| 0.104 | 0.073 | 0.118 | Mucolytic | 0.118 0.057 CID_3025891 | CID_3025891 | |
| 0.065 | 0.035 | 0.071 | Androgen agonist | 0.071 0.03 CID_3025891 | CID_3025891 | |
| 0.08 | 0.05 | 0.084 | Na+ K+ transporting ATPase inhibitor | 0.084 0.047 CID_3025891 | CID_3025891 | |
| 0.137 | 0.107 | 0.137 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.082 | 0.052 | 0.106 | Topoisomerase II alpha inhibitor | 0.106 0.036 CID_3025891 | CID_3025891 | |
| 0.047 | 0.017 | 0.047 | Diamine oxidase inhibitor | |||
| 0.054 | 0.024 | 0.069 | Glucose-6-phosphate isomerase inhibitor | 0.065 0.015 CID_115225 0.069 0.013 CID_3025891 | CID_3025891 | |
| 0.104 | 0.075 | 0.104 | MAP kinase 13 inhibitor | |||
| 0.034 | 0.005 | 0.034 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.114 | 0.085 | 0.114 | Cyclooxygenase 3 inhibitor | |||
| 0.062 | 0.033 | 0.062 | Ryanodine receptor antagonist | |||
| 0.065 | 0.037 | 0.065 | Phosphodiesterase 1C inhibitor | 0.06 0.048 CID_115225 | ||
| 0.059 | 0.031 | 0.059 | Dihydroorotate oxidase inhibitor | 0.056 0.035 CID_115225 | ||
| 0.037 | 0.009 | 0.037 | Purinergic P2Y15 antagonist | 0.032 0.014 CID_115225 0.037 0.009 CID_3025891 | ||
| 0.117 | 0.09 | 0.117 | Alkaline phosphatase inhibitor | |||
| 0.086 | 0.059 | 0.086 | Androgen antagonist | |||
| 0.104 | 0.077 | 0.104 | Nav1.5 sodium channel blocker | |||
| 0.133 | 0.106 | 0.133 | Polo-like kinase-3 inhibitor | |||
| 0.062 | 0.035 | 0.062 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.061 | 0.035 | 0.061 | Alpha 1 adrenoreceptor agonist | |||
| 0.098 | 0.071 | 0.143 | Expectorant | 0.143 0.038 CID_3025891 | CID_3025891 | |
| 0.058 | 0.032 | 0.058 | Protein kinase C epsilon inhibitor | |||
| 0.036 | 0.01 | 0.036 | 5 Hydroxytryptamine 6 agonist | |||
| 0.116 | 0.091 | 0.116 | Tyrosine-protein kinase receptor antagonist | |||
| 0.05 | 0.025 | 0.05 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.045 | 0.02 | 0.045 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.152 | 0.127 | 0.152 | Anticonvulsant | |||
| 0.063 | 0.038 | 0.063 | Carbonic anhydrase stimulant | |||
| 0.068 | 0.043 | 0.068 | MAP kinase kinase 10 inhibitor | |||
| 0.096 | 0.071 | 0.108 | Urease inhibitor | 0.108 0.058 CID_115225 | CID_115225 | |
| 0.066 | 0.042 | 0.066 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.103 | 0.079 | 0.103 | Activin receptor-like kinase 4 inhibitor | |||
| 0.045 | 0.021 | 0.045 | Kainate receptor agonist | 0.039 0.035 CID_3025891 | ||
| 0.035 | 0.011 | 0.035 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.06 | 0.036 | 0.06 | Protein kinase C theta inhibitor | |||
| 0.057 | 0.033 | 0.057 | Ornithine carbamoyltransferase inhibitor | 0.054 0.036 CID_3025891 | ||
| 0.043 | 0.019 | 0.043 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.034 | 0.01 | 0.034 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.046 | 0.023 | 0.046 | Angiotensin AT1 receptor antagonist | |||
| 0.061 | 0.038 | 0.061 | Adenosine A1 receptor antagonist | |||
| 0.038 | 0.016 | 0.038 | Potassium channel small-conductance Ca-activated activator | |||
| 0.131 | 0.109 | 0.144 | Interferon gamma antagonist | 0.144 0.086 CID_3025891 | CID_3025891 | |
| 0.041 | 0.018 | 0.042 | Fumarate hydratase inhibitor | 0.042 0.017 CID_3025891 | CID_3025891 | |
| 0.057 | 0.035 | 0.057 | Sphingosine kinase 2 inhibitor | |||
| 0.062 | 0.04 | 0.062 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.127 | 0.105 | 0.127 | Protein-tyrosine phosphatase inhibitor | |||
| 0.168 | 0.147 | 0.168 | Spasmolytic | |||
| 0.041 | 0.019 | 0.041 | Integrin alpha2 antagonist | |||
| 0.044 | 0.023 | 0.044 | Urate transporter 1 inhibitor | |||
| 0.057 | 0.035 | 0.074 | Glucosylceramidase inhibitor | 0.074 0.019 CID_3025891 | CID_3025891 | |
| 0.041 | 0.02 | 0.041 | Glutamate (mGluR3) antagonist | |||
| 0.047 | 0.026 | 0.047 | Glutamate (mGluR group III) agonist | |||
| 0.061 | 0.041 | 0.061 | Aromatase inhibitor | |||
| 0.04 | 0.02 | 0.04 | Retinoid X alpha receptor agonist | |||
| 0.091 | 0.071 | 0.091 | Bile acid receptor antagonist | |||
| 0.042 | 0.023 | 0.042 | AMPA 4 receptor antagonist | |||
| 0.054 | 0.035 | 0.063 | Alpha-mannosidase inhibitor | 0.063 0.023 CID_3025891 | CID_3025891 | |
| 0.062 | 0.043 | 0.062 | Histone deacetylase SIRT3 inhibitor | |||
| 0.029 | 0.011 | 0.029 | Alpha 1a adrenoreceptor agonist | |||
| 0.054 | 0.035 | 0.054 | Heparanase inhibitor | 0.05 0.046 CID_3025891 | ||
| 0.051 | 0.033 | 0.051 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.078 | 0.06 | 0.078 | Adrenaline agonist | |||
| 0.102 | 0.084 | 0.102 | TRPA1 agonist | |||
| 0.055 | 0.037 | 0.055 | Bromodomain-containing protein 4 inhibitor | |||
| 0.05 | 0.032 | 0.05 | Carbonic anhydrase XIV inhibitor | |||
| 0.04 | 0.023 | 0.04 | Potassium channel Kv1.1 blocker | |||
| 0.042 | 0.025 | 0.042 | Histone deacetylase class I inhibitor | |||
| 0.084 | 0.068 | 0.084 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.056 | 0.039 | 0.056 | 5 Hydroxytryptamine 7 agonist | |||
| 0.061 | 0.045 | 0.061 | 5 Hydroxytryptamine 2A agonist | |||
| 0.08 | 0.064 | 0.08 | GABA A receptor agonist | |||
| 0.061 | 0.046 | 0.061 | Beta 2 adrenoreceptor agonist | |||
| 0.05 | 0.034 | 0.05 | Potassium channel (Inward rectifier) blocker | |||
| 0.022 | 0.007 | 0.026 | Antibiotic Anthracycline-like | 0.026 0.005 CID_3025891 | CID_3025891 | |
| 0.051 | 0.036 | 0.051 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.047 | 0.033 | 0.047 | Benzodiazepine antagonist | |||
| 0.026 | 0.012 | 0.026 | Glutamate (mGluR1a) agonist | |||
| 0.035 | 0.021 | 0.184 | Histone deacetylase 2 inhibitor | 0.184 0.007 CID_115225 | CID_115225 | |
| 0.036 | 0.023 | 0.037 | Phosphoglycerate kinase inhibitor | 0.037 0.023 CID_3025891 | CID_3025891 | |
| 0.031 | 0.017 | 0.031 | CDK4/cyclin D3 inhibitor | |||
| 0.031 | 0.018 | 0.031 | Cyclin E2 inhibitor | |||
| 0.032 | 0.018 | 0.032 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.034 | 0.021 | 0.034 | Melatonin receptor 1A agonist | |||
| 0.059 | 0.046 | 0.059 | Adenosine A2a receptor antagonist | |||
| 0.073 | 0.06 | 0.077 | Keratolytic | 0.077 0.053 CID_3025891 | CID_3025891 | |
| 0.035 | 0.022 | 0.035 | Glutamate (mGluR4) agonist | |||
| 0.139 | 0.127 | 0.139 | Interleukin antagonist | 0.136 0.129 CID_3025891 | ||
| 0.089 | 0.077 | 0.089 | MAP kinase kinase kinase inhibitor | |||
| 0.027 | 0.016 | 0.027 | Integrin alpha2beta1 antagonist | |||
| 0.045 | 0.034 | 0.045 | Purinergic P2X4 antagonist | |||
| 0.063 | 0.052 | 0.063 | CDC7 inhibitor | |||
| 0.034 | 0.023 | 0.034 | Angiotensin II receptor antagonist | |||
| 0.065 | 0.054 | 0.065 | MDM2 inhibitor | |||
| 0.015 | 0.005 | 0.015 | Imidazoline I2 receptor antagonist | |||
| 0.052 | 0.041 | 0.052 | Carbonic anhydrase IX inhibitor | |||
| 0.053 | 0.042 | 0.053 | DNA helicase inhibitor | |||
| 0.025 | 0.015 | 0.025 | 5 Hydroxytryptamine 4 agonist | |||
| 0.042 | 0.032 | 0.042 | Heme oxygenase inhibitor | |||
| 0.024 | 0.013 | 0.024 | Adenosine kinase inhibitor | |||
| 0.071 | 0.061 | 0.071 | Vanilloid 4 agonist | |||
| 0.023 | 0.014 | 0.023 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.09 | 0.081 | 0.109 | Mediator release inhibitor | 0.109 0.059 CID_115225 | CID_115225 | |
| 0.028 | 0.018 | 0.028 | Hedgehog signaling activator | |||
| 0.026 | 0.016 | 0.166 | Histone deacetylase 1 inhibitor | 0.166 0.007 CID_115225 | CID_115225 | |
| 0.028 | 0.02 | 0.028 | Estrogen-related receptor gamma antagonist | |||
| 0.074 | 0.065 | 0.074 | Acetylcholine nicotinic agonist | |||
| 0.109 | 0.101 | 0.109 | Calcium channel blocker | |||
| 0.088 | 0.08 | 0.088 | Phosphodiesterase 6D inhibitor | |||
| 0.081 | 0.073 | 0.081 | Potassium channel activator | |||
| 0.019 | 0.011 | 0.019 | Alpha 2b adrenoreceptor agonist | |||
| 0.043 | 0.035 | 0.052 | Mannosidase inhibitor | 0.052 0.023 CID_3025891 | CID_3025891 | |
| 0.05 | 0.043 | 0.05 | Protein kinase C eta inhibitor | |||
| 0.017 | 0.009 | 0.017 | NMDA receptor phencyclidine site antagonist | |||
| 0.05 | 0.043 | 0.05 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.084 | 0.077 | 0.084 | MAO A inhibitor | |||
| 0.084 | 0.077 | 0.084 | Butyrylcholinesterase inhibitor | |||
| 0.026 | 0.019 | 0.026 | Thymidine phosphorylase inhibitor | |||
| 0.085 | 0.08 | 0.085 | Xanthine oxidase inhibitor | |||
| 0.074 | 0.069 | 0.074 | Calcium antagonist | |||
| 0.057 | 0.052 | 0.057 | Adenosine A2 receptor antagonist | |||
| 0.009 | 0.004 | 0.009 | DNA topoisomerase III inhibitor | |||
| 0.046 | 0.041 | 0.046 | Carbonic anhydrase XII inhibitor | |||
| 0.078 | 0.073 | 0.078 | CC chemokine 5 receptor agonist | |||
| 0.05 | 0.045 | 0.05 | GABA receptor antagonist | |||
| 0.032 | 0.027 | 0.032 | Protein kinase C beta I inhibitor | |||
| 0.028 | 0.023 | 0.028 | MAP3K8 inhibitor | |||
| 0.041 | 0.037 | 0.041 | Dihydroorotase inhibitor | |||
| 0.037 | 0.032 | 0.037 | Membrane dipeptidase inhibitor | |||
| 0.037 | 0.032 | 0.037 | 5 Hydroxytryptamine 2B agonist | |||
| 0.023 | 0.018 | 0.023 | CC chemokine 8 receptor antagonist | |||
| 0.027 | 0.023 | 0.027 | AMPA 3 receptor antagonist | |||
| 0.028 | 0.024 | 0.028 | Purinergic P2Y14 antagonist | |||
| 0.039 | 0.035 | 0.039 | Guanylate cyclase inhibitor | |||
| 0.155 | 0.151 | 0.214 | Immunostimulant | 0.205 0.117 CID_115225 0.214 0.112 CID_3025891 | CID_3025891 | |
| 0.048 | 0.044 | 0.048 | GABA A receptor antagonist | |||
| 0.029 | 0.026 | 0.029 | ATP citrate lysase inhibitor | |||
| 0.032 | 0.029 | 0.032 | Arginase inhibitor | |||
| 0.018 | 0.014 | 0.018 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.014 CID_3025891 | ||
| 0.035 | 0.032 | 0.035 | Glutamate (mGluR group II) antagonist | |||
| 0.031 | 0.028 | 0.031 | Retinoid X receptor agonist | |||
| 0.017 | 0.015 | 0.017 | Complement factor D inhibitor | |||
| 0.015 | 0.012 | 0.017 | Purinergic P2Y1 agonist | 0.017 0.009 CID_3025891 | CID_3025891 | |
| 0.033 | 0.03 | 0.033 | Potassium channel KCNQ activator | |||
| 0.033 | 0.03 | 0.033 | Delayed rectifier potassium channel activator | |||
| 0.024 | 0.022 | 0.024 | Acid ceramidase inhibitor | |||
| 0.026 | 0.023 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.069 | 0.066 | 0.069 | MAP kinase 10 inhibitor | |||
| 0.03 | 0.028 | 0.03 | Glutamate (mGluR3) agonist | |||
| 0.027 | 0.025 | 0.027 | Acetylcholine M4 receptor agonist | |||
| 0.051 | 0.049 | 0.051 | MAP kinase kinase 9 inhibitor | |||
| 0.036 | 0.034 | 0.042 | Histone deacetylase 9 inhibitor | 0.042 0.023 CID_115225 | CID_115225 | |
| 0.116 | 0.114 | 0.116 | Cholinergic | |||
| 0.1 | 0.098 | 0.1 | Nav1.3 sodium channel blocker | |||
| 0.021 | 0.02 | 0.021 | Isoleucine-tRNA ligase inhibitor | |||
| 0.07 | 0.069 | 0.07 | TIE-2 antagonist | |||
| 0.031 | 0.03 | 0.031 | Protein kinase (CK2) beta inhibitor | |||
| 0.035 | 0.034 | 0.035 | DNA-dependent protein kinase inhibitor | |||
| 0.012 | 0.011 | 0.059 | Human herpes virus 5 capsid protein P40 inhibitor | 0.059 0.003 CID_115225 | CID_115225 | |
| 0.017 | 0.016 | 0.017 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.066 | 0.065 | 0.066 | Adenosine A3 receptor antagonist | |||
| 0.07 | 0.069 | 0.071 | Estrogen receptor alpha antagonist | 0.071 0.066 CID_115225 | CID_115225 | |
| 0.009 | 0.008 | 0.009 | Progesterone receptor A antagonist | |||
| 0.015 | 0.016 | 0.016 | Sodium/hydrogen exchanger inhibitor | 0.016 0.014 CID_3025891 | CID_3025891 | |
| 0.031 | 0.032 | 0.042 | Histone deacetylase 7 inhibitor | 0.042 0.022 CID_115225 | CID_115225 | |
| 0.086 | 0.091 | 0.09 | Estrogen receptor beta antagonist | 0.09 0.083 CID_3025891 | CID_3025891 | |
| 0.01 | 0.018 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.007 CID_115225 | CID_115225 | |
| 0.034 | 0.044 | 0.059 | Phosphorylase inhibitor | 0.059 0.025 CID_3025891 | CID_3025891 | |
| 0.016 | 0.027 | 0.073 | Histone deacetylase 3 inhibitor | 0.073 0.009 CID_115225 | CID_115225 | |
| 0.01 | 0.026 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 CID_115225 | CID_115225 | |
| 0.028 | 0.047 | 0.04 | Histone deacetylase 8 inhibitor | 0.04 0.03 CID_115225 | CID_115225 | |
| 0.039 | 0.064 | 0.102 | Aminopeptidase microsomal inhibitor | 0.102 0.017 CID_115225 | CID_115225 | |
| 0.084 | 0.112 | 0.123 | Cholesterol synthesis inhibitor | 0.123 0.062 CID_3025891 | CID_3025891 | |
| 0.027 | 0.061 | 0.085 | Aminopeptidase N inhibitor | 0.085 0.016 CID_115225 | CID_115225 | |
| 0.084 | 0.133 | 0.102 | M17 leucyl aminopeptidase inhibitor | 0.102 0.099 CID_115225 | CID_115225 | |
| 0.04 | 0.094 | 0.074 | HIV-1 integrase (3'-Processing) inhibitor | 0.074 0.037 CID_3025891 | CID_3025891 | |
| 0.008 | 0.067 | 0.019 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.019 0.007 CID_3025891 | CID_3025891 | |
| 0.01 | 0.083 | 0.072 | Histone deacetylase 10 inhibitor | 0.072 0.007 CID_115225 | CID_115225 | |
| 0.104 | 0.185 | 0.119 | Death-associated protein kinase 1 inhibitor | 0.119 0.115 CID_115225 | CID_115225 | |
| 0.008 | 0.118 | 0.138 | Histone deacetylase 5 inhibitor | 0.138 0.007 CID_115225 | CID_115225 | |
| 0.023 | 0.137 | 0.138 | HIV-1 integrase (Strand Transfer) inhibitor | 0.138 0.014 CID_3025891 | CID_3025891 | |
| 0.085 | 0.228 | 0.295 | Antimitotic | 0.295 0.045 CID_3025891 | CID_3025891 | |
| 0.011 | 0.156 | 0.075 | Histone deacetylase class IV inhibitor | 0.075 0.008 CID_115225 | CID_115225 | |
| 0.011 | 0.156 | 0.075 | Histone deacetylase 11 inhibitor | 0.075 0.008 CID_115225 | CID_115225 | |
| 0.043 | 0.197 | 0.08 | Antineoplastic alkaloid | 0.08 0.065 CID_3025891 | CID_3025891 | |
| 0.044 | 0.2 | 0.163 | ATPase (Vacuolar H+) inhibitor | 0.163 0.005 CID_3025891 | CID_3025891 | |
| 0.008 | 0.17 | 0.111 | Histone deacetylase class IIa inhibitor | 0.111 0.008 CID_115225 | CID_115225 | |
| 0.124 | 0.295 | 0.384 | Immunosuppressant | 0.384 0.07 CID_3025891 | CID_3025891 | |
| 0.088 | 0.28 | 0.262 | Antioxidant | 0.262 0.078 CID_3025891 | CID_3025891 | |
| 0.026 | 0.274 | 0.203 | 5-Lipoxygenase inhibitor | 0.203 0.024 CID_115225 | CID_115225 | |
| 0.006 | 0.271 | 0.143 | Histone deacetylase class II inhibitor | 0.143 0.006 CID_115225 | CID_115225 | |
| 0.01 | 0.279 | 0.227 | Antineoplastic antibiotic | 0.227 0.017 CID_3025891 | CID_3025891 | |
| 0.005 | 0.305 | 0.063 | Histone deacetylase 4 inhibitor | 0.063 0.009 CID_115225 | CID_115225 | |
| 0.009 | 0.31 | 0.045 | Macrophage elastase inhibitor | 0.045 0.028 CID_115225 | CID_115225 | |
| 0.007 | 0.328 | 0.059 | Collagenase inhibitor | 0.059 0.017 CID_115225 | CID_115225 | |
| 0.047 | 0.384 | 0.172 | Nitric oxide antagonist | 0.172 0.08 CID_3025891 | CID_3025891 | |
| 0.126 | 0.464 | 0.314 | Antiinflammatory | 0.314 0.202 CID_3025891 | CID_3025891 | |
| 0.005 | 0.43 | 0.13 | Histone deacetylase class IIb inhibitor | 0.13 0.006 CID_115225 | CID_115225 | |
| 0.004 | 0.439 | 0.129 | Histone deacetylase 6 inhibitor | 0.129 0.006 CID_115225 | CID_115225 | |
| 0.084 | 0.568 | 0.267 | Peptidyltransferase inhibitor | 0.267 0.04 CID_3025891 | CID_3025891 | |
| 0.042 | 0.529 | 0.149 | Hepatoprotectant | 0.149 0.111 CID_3025891 | CID_3025891 | |
| 0.011 | 0.566 | 0.054 | ADAM10 endopeptidase inhibitor | 0.054 0.009 CID_115225 | CID_115225 | |
| 0.008 | 0.804 | 0.036 | Aggrecanase 1 inhibitor | 0.036 0.034 CID_115225 | CID_115225 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |